134 related articles for article (PubMed ID: 24252226)
1. STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.
Xu L; Zhou X; Jiang F; Xu L; Yin R
Cancer Epidemiol; 2014 Apr; 38(2):111-7. PubMed ID: 24252226
[TBL] [Abstract][Full Text] [Related]
2. Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.
Tang W; Qiu H; Ding H; Sun B; Wang L; Yin J; Gu H
PLoS One; 2013; 8(12):e82790. PubMed ID: 24349361
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
4. Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.
Qin J; He XF; Wei W; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ
Mol Genet Genomics; 2015 Feb; 290(1):97-114. PubMed ID: 25154511
[TBL] [Abstract][Full Text] [Related]
5. The AURKA gene rs2273535 polymorphism contributes to breast carcinoma risk - meta-analysis of eleven studies.
Guo XG; Zheng L; Feng WB; Xia Y
Asian Pac J Cancer Prev; 2014; 15(16):6709-14. PubMed ID: 25169513
[TBL] [Abstract][Full Text] [Related]
6. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of phospholipase C epsilon 1 polymorphism and cancer risk.
Zhang Y; Wang R; Zhu L; Zhang S; Yuan H; Jiang H
Cancer Biomark; 2013 Jan; 13(6):483-9. PubMed ID: 24595086
[TBL] [Abstract][Full Text] [Related]
8. Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.
Dai ZJ; Kang HF; Wang XJ; Shao YP; Lin S; Zhao Y; Ren HT; Min WL; Wang M; Liu XX
Cancer Cell Int; 2014; 14(1):91. PubMed ID: 25253995
[TBL] [Abstract][Full Text] [Related]
9. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
10. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
11. Association between IL13 gene polymorphisms and susceptibility to cancer: a meta-analysis.
Su T; Mi Y; Zhang L; Wang S; Lu H; Shi L; Sun H; Wu X; Zhang W; Zuo L; Zou J
Gene; 2013 Feb; 515(1):56-61. PubMed ID: 23246181
[TBL] [Abstract][Full Text] [Related]
12. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.
Tang W; Qiu H; Jiang H; Wang L; Sun B; Gu H
PLoS One; 2014; 9(3):e90328. PubMed ID: 24598702
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies.
Wei BB; Xi B; Wang R; Bai JM; Chang JK; Zhang YY; Yoneda R; Su JT; Hua LX
Cancer Genet Cytogenet; 2010 Jan; 196(1):68-75. PubMed ID: 19963138
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
15. Two nonsynonymous polymorphisms (F31I and V57I) of the STK15 gene and breast cancer risk: a meta-analysis based on 5966 cases and 7609 controls.
Qin K; Wu C; Wu X
J Int Med Res; 2013 Aug; 41(4):956-63. PubMed ID: 23803310
[TBL] [Abstract][Full Text] [Related]
16. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
17. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
[TBL] [Abstract][Full Text] [Related]
18. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Qiu LX; Wang Y; Xia ZG; Xi B; Mao C; Wang JL; Wang BY; Lv FF; Wu XH; Hu LQ
Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
[TBL] [Abstract][Full Text] [Related]
19. The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.
Han SX; Wang L; Wu DQ
Cancer Epidemiol; 2012 Aug; 36(4):e201-6. PubMed ID: 22402308
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.
Chong ET; Goh LP; See EU; Chuah JA; Chua KH; Lee PC
Asian Pac J Cancer Prev; 2016; 17(2):647-53. PubMed ID: 26925658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
